Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Accumulated Expenses (2021 - 2025)

Historic Other Accumulated Expenses for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to $148572.0.

  • HeartSciences' Other Accumulated Expenses fell 1443.87% to $148572.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $148572.0, marking a year-over-year decrease of 1443.87%. This contributed to the annual value of $29927.0 for FY2025, which is 1235.83% down from last year.
  • Latest data reveals that HeartSciences reported Other Accumulated Expenses of $148572.0 as of Q4 2025, which was down 1443.87% from $215334.0 recorded in Q3 2025.
  • HeartSciences' 5-year Other Accumulated Expenses high stood at $389186.0 for Q3 2022, and its period low was $1220.0 during Q2 2021.
  • In the last 5 years, HeartSciences' Other Accumulated Expenses had a median value of $153596.0 in 2023 and averaged $146268.2.
  • The largest annual percentage gain for HeartSciences' Other Accumulated Expenses in the last 5 years was 388327.87% (2023), contrasted with its biggest fall of 4561.66% (2023).
  • Over the past 5 years, HeartSciences' Other Accumulated Expenses (Quarter) stood at $1220.0 in 2021, then soared by 23807.38% to $291670.0 in 2022, then tumbled by 45.62% to $158620.0 in 2023, then rose by 9.47% to $173644.0 in 2024, then dropped by 14.44% to $148572.0 in 2025.
  • Its Other Accumulated Expenses was $148572.0 in Q4 2025, compared to $215334.0 in Q3 2025 and $29927.0 in Q2 2025.